Current and Recent Fellows in our Blood and Marrow Transplant Program

Current Fellows in our Blood & Marrow Transplant Program:

Dr. Abdulaziz Hamadah  – July 1, 2009 – present

Supported by the government of Kuwait

  • Published manuscript:
    • Abdulaziz Hamadah, Sheryl A. McDiarmid, Lothar B. Huebsch, Rakesh Patel, David S. Allan, Management of patients transferred to ICU during the conditioning phase of allogeneic hematopoietic stem cell transplantation, Intensive Care Med, 2009; DOI 10.1007/s00134-009-1583-4 (in press).
  • Employment: will be appointed to the academic staff in Kuwait, pending completion of BMT training

Dr. David Conrad –July 1, 2009 – present

Supported by research stipend from Ministry of Health and Long-term Care and by The Ottawa Hospital Foundation

  • Candidate for M.Sc with Drs. Bruce McKay, John Bell & Harry Atkins.
  • Enrolled in Clinician-Scientist Program

 

Recent Fellows in our Blood and Marrow Transplant Program:

Dr. Dawn Sheppard – July 1, 2010 – June 30, 2012

Supported by Canadian Blood Services and unrestricted educational grants from Genzyme Canada and Bristol Myers Squibb

  • Employment: appointed to academic staff in Hematology at the University of Ottawa

 Dr. Joanne Hickey – July 1, 2008 – June 30, 2009

Supported by Orthobiotech unrestricted educational grant for BMT Training and by the Division of Hematology, The Ottawa Hospital

  • Candidate for M.Ed program
  • Employment: Appointed to the academic staff at Memorial University, St. John’s, Newfoundland

Dr. Ayman Al-Hejazi – September 1, 2007 to July 31, 2008

Supported by the government of Saudi Arabia

  • Research Project Ongoing: Post-thaw apoptosis in autologous PBSC grafts and delayed hematopoietic engraftment
  • Employment – appointed to academic staff at King Abdulaziz Medical City Hospital in Riyadh, Saudi Arabia

Dr. Amal Al-Beihany – July 1, 2006 to June 30, 2007

Supported by the cultural bureau of Saudi Arabia

  • Manuscript submitted for publication:
  • Abstract submitted to 29th International Symposium on Critical Care and Emergency Medicine, Brussels, March 27-29, 2009:
    • Omar Hayani, Amal Al-Beihany, Ayman Kharaba, Andrew Chou, Alan Baxter, Rakesh Patel, David Allan. Impact of critical care outreach in hematopoietic stem cell transplantation. (manuscript submitted to BMT)
  • Employment: appointed to academic staff at the King Faisal Hospital, Riyadh, Saudi Arabia

Dr. Jason Tay – July 1, 2005 to June 30, 2007

Supported by Canadian Blood Services postdoctoral fellowship award and The Division of Hematology, The Ottawa Hospital

  • Completed MSc (Clin Epi).
  • Published manuscripts:
    • Tay J, Tinmouth A, Fergusson D, Huebsch L, Allan DS.  Systematic review of controlled clinical trials on the use of ursodeoxycholic acid in the prevention of hepatic veno-occlusive disease following hematopoietic transplantation. Biol Blood and Marrow Transplantation, 2007; 13:206-17.
    • Tay J, Tinmouth A. Observational studies: what is a cohort study? Transfusion, 2007; 47:1115-7.
    • Kasbia G, Al-Gahtani F, Tay J, LabontĂ© L, Tinmouth A, Ramsay T, Gillingham A, Yang L, Halpenny M, Giulivi A, McDiarmid S, Huebsch L & Allan DS. Reduced hemoglobin on day of PBPC collection influences graft content of vascular progenitors and organ toxicity following autologous hematopoietic stem cell transplantation. Transfusion, 2008; 48:2421-28.
    • LabontĂ© L, Iqbal T, Zaidi MA, McDiarmid SA, Huebsch LB, Tay J, Atkins H, Allan DS. Utility of co-morbidity assessment in predicting transplant-related toxicity following autologous hematopoietic transplantation for multiple myeloma. Biol Blood Marrow Transplant, 2008; 14:1039-44.
  • Employment: appointed to academic staff in Hematology at the University of Ottawa